NCT04906031 2021-06-09
Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 Mutations
First Affiliated Hospital of Jinan University
Phase 2 Unknown
Clinical Trials
4 trialsNCT00498979 2020-07-24
Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other Cancers
Case Comprehensive Cancer Center
Phase 1 Completed
NCT00629200 2018-11-15
Sodium Stibogluconate With Interferon Alpha-2b for Patients With Advanced Malignancies
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00311558 2018-01-26
Sodium Stibogluconate and Interferon in Treating Patients With Advanced Solid Tumors, Lymphoma, or Myeloma
The Cleveland Clinic
Phase 1 Terminated